VEREGEN®

VEREGEN®
Product Description

• Innovative originator herbal product • Molecule: Sinecatechins (extract from green tea leaves) •Therapeutic Indications: External anogenital warts caused by Human Papilloma Virus (Type 6 and 11)

• Formulation: Ointment •Global in-market sales 2020: ~€11m / ~105k units
• Patent protection: up to 2029 plus unique, complex manufacturing process of the API provides long-term product protection 
• Broad mode of action supports development in further indications

DERMAGO

  • Country/Region:
    Germany
  • On CPHI since:
    2022
  • Employees:
    1 - 24
Company types
Consultancy
Distributor/Import Export
Licensee
Pharmaceutical company
Wholesale/Retail
Primary activities
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Specifications
  • Details
    Ointment, on skin
  • Selling Points
    Natural Ingredients; •Innovative originator herbal product
  • Model
    Licensing-and Supply
  • Supplied from
    Germany
  • Measured In
    gram

DERMAGO

  • Country/Region:
    Germany
  • On CPHI since:
    2022
  • Employees:
    1 - 24
Company types
Consultancy
Distributor/Import Export
Licensee
Pharmaceutical company
Wholesale/Retail
Primary activities
Out-licensing specialist
Pharmaceutical Company (generic finished products)

More Products from DERMAGO (2)

  • BELOREN®

    Product BELOREN®

    • Generic version of Skinoren/Finacea (Leo Pharma/Bayer)
    • Molecule: Azelaic Acid • Market: L700 (ACNE VULGARIS) & L71 (ROSACEA) • Therapeutic Indications: Creme formulation indicated for mild to moderate acne vulgaris / gel formulation indicated for mild to moderate papular-p...
  • SKINATAN®

    Product SKINATAN®

    • Generic version of Advantan®, Bayer • Molecule: Methylprednisolone Aceponate 0.1 % (4th generation Topical Glucocorticoids)

    • Market: D7A (Plain Topical Corticosteroids) •Therapeutic Indications: Dermatitis, Atopic Dermatitis, Contact Dermatitis (indication differs for...